Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement

Study limitation reported by the research below: “The 'practice changing' impact flag reflects the breadth and clinical scope of EASO/EFAD/ECPO guidance on a rapidly evolving therapy class, not a single pivotal trial result.”